Recent Articles by Keith Speights
 The healthcare giant has stumbled lately, but J&J still has plenty to offer investors. |
 This stock is a cash cow with a strong moat and great growth prospects. |
 Newly identified potential issues with CRISPR-Cas9 gene editing aren't as worrisome as you might think. |
 These stocks have what it takes to help meet your financial needs in retirement beyond what Social Security can provide. |
 Which cloud-based healthcare technology stock wins in a head-to-head matchup? |
 These two drug stocks have a lot to offer income investors and value investors. |
 Here's why terrific results for a revolutionary new cancer therapy left investors unsatisfied. |
 These hot stocks are more alike than they might appear at first glance. |
 This biotech stock is skyrocketing. Here's why -- maybe. |
 Which big pharma stock wins in a head-to-head match-up? |
